bisantrene has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crain, SM; Forastiere, AA; Garbino, C; Kasdorf, H; Perry, DJ; Tipping, SJ; Van Echo, DA | 1 |
| Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J | 1 |
2 other study(ies) available for bisantrene and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Topics: Adult; Aged; Anthracenes; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms | 1983 |